Cargando…
The impact of home treatment and self-administration of omalizumab on chronic urticaria
BACKGROUND: Patients suffering from Chronic Spontaneous Urticaria (CSU) may be recalcitrant to treatment with high dose second-generation antihistamines. These patients are, according to international guidelines, eligible to treatment with omalizumab. Treatment with omalizumab has proven to be very...
Autores principales: | Wiuff, Anne Christine, Knudsgaard Wiis, Malthe Alexander, Heilskov, Sofine, Frølunde, Anne Sofie, Sørensen, Jennifer Astrup, Deleuran, Mette, Thomsen, Simon Francis, Vestergaard, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731880/ https://www.ncbi.nlm.nih.gov/pubmed/36531648 http://dx.doi.org/10.1016/j.waojou.2022.100725 |
Ejemplares similares
-
Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature
por: Heilskov, Sofine, et al.
Publicado: (2020) -
Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
por: Pedersen, Nadja Højgaard, et al.
Publicado: (2023) -
A Long Term Case Series Study of the Effect of Omalizumab on Chronic Spontaneous Urticaria
por: Lefévre, Anna Cecilie, et al.
Publicado: (2013) -
Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China()
por: Wang, Ao, et al.
Publicado: (2022) -
Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
por: Ivyanskiy, Ilya, et al.
Publicado: (2012)